Visual Field Testing for Glaucoma and Other Diseases

Visual field testing plays a critical role in catching conditions early, tracking changes over time, and guiding treatment decisions. Its value extends well beyond glaucoma to a variety of eye and brain-related disorders.

Glaucoma is often called the 'silent thief of sight' because it typically causes peripheral vision loss so gradually that patients do not notice it until significant damage has occurred. Visual field testing can reveal characteristic patterns of loss, such as arcuate scotomas and nasal steps, well before you would perceive any change in your day-to-day vision. Early detection through regular testing is one of the most effective ways to preserve vision, particularly for patients who are classified as glaucoma suspects or who have known risk factors.

For patients already diagnosed with glaucoma, repeated visual field tests over months and years create a trend analysis that shows whether the disease is stable or worsening. Our glaucoma specialists compare sequential test results using statistical software that can detect progression earlier than a single snapshot would allow. This information is essential for deciding when to adjust medications, recommend laser treatment, or consider surgery.

Visual field defects are not exclusive to glaucoma. Specific patterns of field loss can point to brain tumors, strokes, optic nerve inflammation, or pituitary gland disorders. For example, a loss affecting the same side of the visual field in both eyes (homonymous hemianopia) often indicates a problem along the visual pathway in the brain rather than within the eye itself. Patients with a family history of glaucoma or neurological disease benefit especially from routine visual field assessment.

Visual field testing is most commonly used to detect and monitor glaucoma, but it also plays a role in diagnosing optic neuritis, pituitary tumors, brain tumors, stroke-related vision loss, multiple sclerosis, and certain retinal conditions such as retinitis pigmentosa. The specific pattern of visual field loss helps your doctor determine the underlying cause and guide appropriate treatment.

A normal visual field report shows relatively uniform sensitivity across all tested points, with a natural blind spot corresponding to the optic nerve head. Abnormal results display areas of reduced sensitivity or complete loss, often represented by darker shading on the printout. Glaucoma typically produces arcuate-shaped defects that follow the pattern of nerve fiber bundles, while neurological causes tend to produce defects that respect the vertical midline of the visual field.

For patients with established glaucoma, our glaucoma specialists generally recommend testing two to three times per year during the first two years after diagnosis in order to establish a reliable baseline and detect early progression. Once a stable trend is established, annual testing is often sufficient for well-controlled patients. Those at higher risk for rapid progression may require more frequent monitoring.

No special preparation is required. You should bring your current glasses or contact lenses to the appointment, as the test is performed with your best corrected vision. Getting a good night of sleep before the test can help reduce fatigue-related errors. Avoid caffeine in large amounts before testing, as it may affect concentration. If you use glaucoma eye drops, continue taking them on your regular schedule unless instructed otherwise.

Visual field testing and OCT imaging provide complementary information. OCT measures the physical thickness of the retinal nerve fiber layer and can detect structural damage before functional vision loss becomes apparent on a visual field test. Visual field testing, on the other hand, measures how well you actually see at different points in your field of vision. Together, these two tests give your doctor a more complete understanding of glaucoma status and progression than either test alone. You can learn more about how to interpret your OCT and visual field results on our dedicated page.

Visual field testing is a medically necessary diagnostic procedure for glaucoma and many other conditions, and it is covered by most medical insurance plans, including Medicare. Coverage applies when the test is ordered for a documented medical indication such as glaucoma diagnosis, monitoring, or evaluation of unexplained vision loss. Your insurance plan may have specific copay or deductible requirements, so we recommend checking with your carrier before your visit if you have questions about out-of-pocket costs.